Article Sidebar
Published:
Apr 21, 2023Keywords:
Article Details
The Journal is owned, published, and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. Open access authors retain the copyrights of their papers, with the work three months after publication simultaneously licensed under a Creative Commons Attribution License (Attribution, Non-Commercial, No Derivatives” 4.0) - (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Main Article Content
Carbamazepine induced drug reaction with eosinophilia and Systemic symptoms syndrome
Abstract
Background: Drug reaction with eosinophilia and systemic symptoms syndrome is a rare adverse, life threatening drug reaction caused by several drugs including Carbamazepine. The objective of this report is to create awareness of this life threatening reaction to a commonly prescribed drug for seizure disorders.
Methods: This is a case report of drug eosinophilia syndrome in a 33-year old female following clinical and laboratory evaluation at the skin clinic for generalized erythematous rashes following the use of Carbamazepine.
Results: She was found to have generalized, scaly, erythematous papules, patches and plagues. Laboratory results included blood eosinophilia, elevated liver enzymes and histopathology report of spongiotic dermatitis with eosinophilic infiltrates.
Conclusion: Drug reaction with eosinophilia and systemic symptoms syndrome can be caused by Carbamazepine. A diagnosis of this rare life threatening drug reaction should be suspected in patients presenting with generalized erythematous rashes following the use of Carbamazepine
